Identification of CFTR variants in Latino patients with cystic fibrosis from the Dominican Republic and Puerto Rico
- PMID: 31665830
- PMCID: PMC7571374
- DOI: 10.1002/ppul.24549
Identification of CFTR variants in Latino patients with cystic fibrosis from the Dominican Republic and Puerto Rico
Abstract
Background: In cystic fibrosis (CF), the spectrum and frequency of CFTR variants differ by geography and race/ethnicity. CFTR variants in White patients are well-described compared with Latino patients. No studies of CFTR variants have been done in patients with CF in the Dominican Republic or Puerto Rico.
Methods: CFTR was sequenced in 61 Dominican Republican patients and 21 Puerto Rican patients with CF and greater than 60 mmol/L sweat chloride. The spectrum of CFTR variants was identified and the proportion of patients with 0, 1, or 2 CFTR variants identified was determined. The functional effects of identified CFTR variants were investigated using clinical annotation databases and computational prediction tools.
Results: Our study found 10% of Dominican patients had two CFTR variants identified compared with 81% of Puerto Rican patients. No CFTR variants were identified in 69% of Dominican patients and 10% of Puerto Rican patients. In Dominican patients, there were 19 identified CFTR variants, accounting for 25 out of 122 disease alleles (20%). In Puerto Rican patients, there were 16 identified CFTR variants, accounting for 36 out of 42 disease alleles (86%) in Puerto Rican patients. Thirty CFTR variants were identified overall. The most frequent variants for Dominican patients were p.Phe508del and p.Ala559Thr and for Puerto Rican patients were p.Phe508del, p.Arg1066Cys, p.Arg334Trp, and p.I507del.
Conclusions: In this first description of the CFTR variants in patients with CF from the Dominican Republic and Puerto Rico, there was a low detection rate of two CFTR variants after full sequencing with the majority of patients from the Dominican Republic without identified variants.
Keywords: CFTR variants; Latino; health disparities; whole genome sequencing.
© 2019 Wiley Periodicals, Inc.
Conflict of interest statement
CONFLICT OF INTERESTS
The authors declare that there are no conflict of interests.
Figures
References
-
- Cystic Fibrosis Foundation. Cystic fibrosis Foundation Patient Registry, 2017 Annual Data Report to the Center Directors. Bethesda, MD: Cystic Fibrosis Foundation; 2017.
-
- Watts KD, Layne B, Harris A, McColley SA. Hispanic infants with cystic fibrosis show low CFTR mutation detection rates in the Illinois newborn screening program. J Genet Couns. 2012;21(5):671–675. - PubMed
-
- Schrijver I, Pique L, Graham S, Pearl M, Cherry A, Kharrazi M. The spectrum of CFTR variants in non-White cystic fibrosis patients. J Mol Diagn. 2016;18(1):39–50. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 ES015794/ES/NIEHS NIH HHS/United States
- K23 HL133437/HL/NHLBI NIH HHS/United States
- R01 HL120393/HL/NHLBI NIH HHS/United States
- R01MD010443/MD/NIMHD NIH HHS/United States
- HHSN268201600032C/ES/NIEHS NIH HHS/United States
- 3R01HL-120393-02S1/HL/NHLBI NIH HHS/United States
- R01HL135156/HL/NHLBI NIH HHS/United States
- R01HL117004/HL/NHLBI NIH HHS/United States
- HHSN268201800001C/HL/NHLBI NIH HHS/United States
- 1K23HL133437-01A1/HL/NHLBI NIH HHS/United States
- R01 HL117004/HL/NHLBI NIH HHS/United States
- R01ES015794/ES/NIEHS NIH HHS/United States
- 1X01HL134589/HL/NHLBI NIH HHS/United States
- R01 HL117626/HL/NHLBI NIH HHS/United States
- R01 MD010443/MD/NIMHD NIH HHS/United States
- R01 HL135156/HL/NHLBI NIH HHS/United States
- L60 MD010865/MD/NIMHD NIH HHS/United States